Unani treatment for postmenopausal vaginal atrophy

Effect of vaginal application of Tukhme Katan in post menopausal vaginal atrophy - A pre and post Interventional Analytical Study without control

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053676

Enrollment

Registered

2023-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

Intervention1: Tukhme Katan (Linum usitatissimum): Ointment of Tukhme Kataan will be prepared as per the standard method of preparation and will be applied topically per vaginum. One application per

Eligibility

Inclusion criteria

Inclusion criteria: Women had natural menopause confirmed by amenorrhea of at least 12 months Women had symptoms of vaginal atrophy

Exclusion criteria

Exclusion criteria: Vaginal infection, and UTI H/o hysterectomy Current h/o taking HRT H/o undiagnosed vaginal bleeding K/c/o systemic illnesses, and malignancy

Design outcomes

Primary

Measure	Time frame
Clinical ImprovementTimepoint: 8 weeks	—

Secondary

Measure	Time frame
Laboratory ImprovementTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactProf Ismath Shameem

National Institute of Unani Medicine

dr.ismaths@gmail.com9538274583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026